´ëÇѳ»ºÐºñÇÐȸ (¿Â¶óÀÎ) AOCE-SICEM 2020 Virtual Congress : 2020-10-29±³À°ÀÏÀÚ : 2020-10-29
±³À°Àå¼Ò : ¿Â¶óÀÎ ¿¬¼ö±³À°(½Ç½Ã°£ È»ó °ÀÇ), ¿Â¶óÀÎ ¿¬¼ö±³À°(³ìÈ °¿¬ ¿µ»ó ¼ÛÃâ)
±³À°ÁÖÁ¦ :
(¿Â¶óÀÎ) AOCE-SICEM 2020 Virtual Congress ÁÖÃÖ±â°ü : ´ëÇѳ»ºÐºñÇÐȸ
´ã´çÀÚ : ÇмúÀ§¿øȸ
¿¬¶ôó : 02-564-4367
À̸ÞÀÏ :
aoce-sicem2020@intercom.co.kr ±³À°Á¾·ù : ³»°ú, ¿Ü°ú, ÇÙÀÇÇаúÀÇ»çÇÐ, ºÐÀÚ»ý¹°ÇÐ,
Âü¼®¿¹»óÀοø : 1500¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 26 ½Ã°£ 20ºÐ
¼¼ºÎ¼ö°·á : 150,000¿ø
ºñ°í 1. ÀÇ»ç, ±³¼ö - KES ȸ¿ø: 10¸¸¿ø / KES ¹Ìȸ¿ø: 15¸¸¿ø 2. Àü°øÀÇ, ÀüÀÓÀÇ, °£È£»ç, ¿¬±¸ÀÚ, ±âŸ - KES ȸ¿ø: 5¸¸¿ø / KES ¹Ìȸ¿ø: 10¸¸¿ø * º» Çà»ç´Â LIVE°ÀÇ¿Í ³ìÈµÈ VOD°ÀÇ·Î ÁøÇàµÇ¸ç, VOD °ÀǵéÀº ¾Æ·¡ ½Ã°£¿¡ °ü°è¾øÀÌ ´çÀÏ ÀÚÁ¤±îÁö ÆíÇѽ𣿡 º¼ ¼ö ÀÖµµ·Ï ¿î¿µÇÒ ¿¹Á¤ÀÔ´Ï´Ù.
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±âŸ 10¿ù 29ÀÏ ¿Â¶óÀÎ 08:30~08:50 Hot Issues ()
±³À°½Ã°£ 10¿ù 29ÀÏ ¿Â¶óÀÎ 08:50~09:30 Adrenal Masses – When to be Concerned: Benignity, Malignancy & More Gary Hammer(University of Michigan)
±³À°½Ã°£ 10¿ù 29ÀÏ ¿Â¶óÀÎ 09:30~09:50 National Survey of Iodine Intake and Its Relations to Thyroid Disorders in Japan -Epidemiological Study on 32,000 Schoolchildren and 2500 Adults 2014 to 2019 Yozen Fuse(Foundation for Growth Science)
±³À°½Ã°£ 10¿ù 29ÀÏ ¿Â¶óÀÎ 09:50~10:10 Iodine Intake and Prevalence of Thyroid Disorders in Malaysia Mafauzy Mohamed(Universiti Sains Malaysia)
±³À°½Ã°£ 10¿ù 29ÀÏ ¿Â¶óÀÎ 10:10~10:30 Autoimmunity, Iodine Status, Anemia, Stunting and Food Containing Iodine in IDD Replete Areas in Indonesia Tjokorda Gde Dalem Pemayun(Diponegoro University)
±³À°½Ã°£ 10¿ù 29ÀÏ ¿Â¶óÀÎ 10:30~10:50 Elimination of Iodine Deficiency in Thailand: The Work Never Ends Rajata Rajatanavin(Ramathibodi Hospital Mahidol University)
Åä·Ð 10¿ù 29ÀÏ ¿Â¶óÀÎ 10:50~11:00 Live Q&A ()
±³À°½Ã°£ 10¿ù 29ÀÏ ¿Â¶óÀÎ 11:00~11:30 The Ominous Triad of Adipose Tissue Dysfunction: Inflammation, Fibrosis, and Impaired Angiogenesis Clair Crewe(UT Southwestern Medical Center)
±³À°½Ã°£ 10¿ù 29ÀÏ ¿Â¶óÀÎ 11:30~12:00 Feeding-regulatory Peptides in Type 2 DM and Obesity Masamitsu Nakazato(University of Miyazaki)
±³À°½Ã°£ 10¿ù 29ÀÏ ¿Â¶óÀÎ 12:00~12:30 Adipocyte Differentiation and Predisposition for T2DM among Asian Indians Sri Venkata Madhu(UCMS-GTBHospital)
ÈÞ½Ä 10¿ù 29ÀÏ ¿Â¶óÀÎ 12:30~13:30 ÈÞ½Ä ()
±âŸ 10¿ù 29ÀÏ ¿Â¶óÀÎ 13:30~13:50 Opening Address ()
±³À°½Ã°£ 10¿ù 29ÀÏ ¿Â¶óÀÎ 13:50~14:30 Role of Autophagy in the Development and Treatment of Diabetes À̸í½Ä(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 10¿ù 29ÀÏ ¿Â¶óÀÎ 14:30~15:00 Epidemiology of Postoperative Hypoparathyroidism in South Korea ¾È¼ºº¹(ÀÌÈ¿©´ë)
±³À°½Ã°£ 10¿ù 29ÀÏ ¿Â¶óÀÎ 15:00~15:30 Application of Big Data for Musculoskeletal Cell Differentiation Using DNase-seq Yuuki Imai(Ehime University)
±³À°½Ã°£ 10¿ù 29ÀÏ ¿Â¶óÀÎ 15:30~16:00 Contributions to Osteoporosis and Metabolic Diseases Research in Asia: The Vietnam Osteoporosis Study (VOS) Tuan Nguyen(Garvan Institute of Medical Research (Australia); Ton Duc Thang University (Vietnam))
±³À°½Ã°£ 10¿ù 29ÀÏ ¿Â¶óÀÎ 16:00~16:30 Diagnostic Utility of Data Failed Cannulation of the Right Adrenal Vein in Primary Aldosteronism ±èÀçÇö(¼º±Õ°üÀÇ´ë »ï¼º¼¿ïº´¿ø ³»ºÐºñ³»°ú)
±³À°½Ã°£ 10¿ù 29ÀÏ ¿Â¶óÀÎ 16:30~17:00 Metanephrine: Plasma vs Urine? Roderick Clifton-Bligh(University of Sydney)
±³À°½Ã°£ 10¿ù 29ÀÏ ¿Â¶óÀÎ 17:00~17:30 Changing Concepts in Adrenal Insufficiency Paul Stewart(University of Leeds)
±âŸ 10¿ù 29ÀÏ ¿Â¶óÀÎ 17:30~17:50 Daily Highlights ()
±³À°½Ã°£ 10¿ù 29ÀÏ ¿Â¶óÀÎ 09:00~09:20 Screening, Diagnosis and Prognosis of Primary Aldosteronism Vin-Cent Wu(National Taiwan University Hospital)
±³À°½Ã°£ 10¿ù 29ÀÏ ¿Â¶óÀÎ 09:20~09:40 Subtyping (Including AVS, Nuclear Medicine, and Other Methods) and Management Takuyuki Katabami(St. Marianna University School of Medicine Yokohama City Seibu Hospital)
Åä·Ð 10¿ù 29ÀÏ ¿Â¶óÀÎ 09:40~11:10 Discussion ()
±³À°½Ã°£ 10¿ù 29ÀÏ ¿Â¶óÀÎ 09:00~09:30 To Be Discussed Kevin Williams(UT-Southwestern Medical Center/Internal Medicine)
±³À°½Ã°£ 10¿ù 29ÀÏ ¿Â¶óÀÎ 09:30~10:00 To Be Discussed Young-Bum Kim(Harvard Medical School)
±³À°½Ã°£ 10¿ù 29ÀÏ ¿Â¶óÀÎ 10:00~10:30 Hypothalamic Control in Metabolic Function of Aging ±è¹Î¼ö(Çѱ¹°úÇбâ¼ú¿¬±¸¿ø/°úÇбâ¼ú¿¬ÇÕ´ëÇб³)
±³À°½Ã°£ 10¿ù 29ÀÏ ¿Â¶óÀÎ 09:00~09:30 To Be Discussed Hidetaka Suga(Nagoya University)
±³À°½Ã°£ 10¿ù 29ÀÏ ¿Â¶óÀÎ 09:30~10:00 Triacylglycerols: Biomarker to Biology ±¸Ã¶·æ(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 10¿ù 29ÀÏ ¿Â¶óÀÎ 11:00~11:30 Cancer and Bone Interactions: Osteoblasts-Mediated Regulation of Anti-Tumoral Immunity in Bone ¹Ú¼®ÀÎ(°í·Á´ëÇб³ ÀÇ°ú´ëÇÐ)
±³À°½Ã°£ 10¿ù 29ÀÏ ¿Â¶óÀÎ 11:30~12:00 Targeting RANKL in Bone Metastasis Kazuo Okamoto(Graduate School of Medicine and Faculty of Medicine The University of Tokyo)
±³À°½Ã°£ 10¿ù 29ÀÏ ¿Â¶óÀÎ 12:00~12:30 (Pseudo) Hypoparathyroidism in Japan Rieko Takatani(Chiba University)
±³À°½Ã°£ 10¿ù 29ÀÏ ¿Â¶óÀÎ 11:00~11:30 NAFLD and Cardiometabolic Diseases the Insight of Genetics ±¸º¸°æ(¼¿ïƯº°½Ã º¸¶ó¸Åº´¿ø)
±³À°½Ã°£ 10¿ù 29ÀÏ ¿Â¶óÀÎ 11:30~12:00 NAFLD and Cardiovascular Disease Stergios Polyzos(Medical School Aristotle University of Thessaloniki)
±³À°½Ã°£ 10¿ù 29ÀÏ ¿Â¶óÀÎ 12:00~12:30 Management of NAFLD Alice Pik Shan Kong(The Chinese University of Hong Kong)
±³À°½Ã°£ 10¿ù 29ÀÏ ¿Â¶óÀÎ 11:00~11:30 Sarcopenia and Sarcopenic Obesity in Cardiovascular Risk ±èųâ(ÀÎÁ¦ÀÇ´ë)
±³À°½Ã°£ 10¿ù 29ÀÏ ¿Â¶óÀÎ 11:30~12:00 Blood Pressure Variation in Cardiovascular Risk ±è¹Ì°æ(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 10¿ù 29ÀÏ ¿Â¶óÀÎ 12:00~12:30 NAFLD and Subclinical Diastolic Heart Failure °Àº¼®(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 10¿ù 29ÀÏ ¿Â¶óÀÎ 13:00~13:30 Overview of Familinal Hypercholesterolemia ÀÌ»óÇÐ(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 10¿ù 29ÀÏ ¿Â¶óÀÎ 13:30~14:00 FH Management in Taiwan Ta-Chen Su(National Taiwan University Hospital)
±³À°½Ã°£ 10¿ù 29ÀÏ ¿Â¶óÀÎ 14:00~14:30 Role of PCSK9 inhibitor in patients with FH Brian Tomlinson(Macau University of Science & Technology)
±³À°½Ã°£ 10¿ù 29ÀÏ ¿Â¶óÀÎ 15:00~15:30 Making a Pituitary Gland in a Dish Hidetaka Suga(Nagoya University)
±³À°½Ã°£ 10¿ù 29ÀÏ ¿Â¶óÀÎ 15:30~16:00 Precision Medicine in Pituitary Diseases ±¸Ã¶·æ(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 10¿ù 29ÀÏ ¿Â¶óÀÎ 15:00~15:30 CARERARE-Platform for Rare Diseases Using Nation-wide Big Data ¹èÀçÇö(°í·Á´ëÇб³ ¾È¾Ïº´¿ø)
±³À°½Ã°£ 10¿ù 29ÀÏ ¿Â¶óÀÎ 15:30~16:00 The Rare Diseases and Pediatric Clinical Research Networks in Europe Jacques Demotes(ECRIN)
±³À°½Ã°£ 10¿ù 29ÀÏ ¿Â¶óÀÎ 16:00~16:30 Rare Endocrine Disease-common Data Model (RED-CDM) È«³²±â(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 10¿ù 29ÀÏ ¿Â¶óÀÎ 16:30~17:00 Thyroid Function & Quality of Life of Patients Shuhang Xu(Nanjing University of Chinese Medicine)
±³À°½Ã°£ 10¿ù 29ÀÏ ¿Â¶óÀÎ 17:00~17:30 Thyroid Function and Metabolic Parameters of Patients ±è¹ÎÈñ(ÀºÆò¼º¸ðº´¿ø)
±³À°½Ã°£ 10¿ù 29ÀÏ ¿Â¶óÀÎ 17:30~18:00 T3/T4 Combination Therapy in Hypothyroidism ±è¿ø¹è(¼¿ï¾Æ»êº´¿ø)
±³À°½Ã°£ 10¿ù 29ÀÏ ¿Â¶óÀÎ 16:30~17:00 Medical Treatment for Pediatric Thyroid Cancer ÀÌ¿µ¾Æ(¼¿ï´ëÇб³º´¿ø)
±³À°½Ã°£ 10¿ù 29ÀÏ ¿Â¶óÀÎ 17:00~17:30 Maximize Effectiveness of Radioiodine Treatment for Pediatric Differentiated Thyroid Cancer Patients ¾Èº´Ã¶(°æºÏ´ëÇб³ ÀÇ°ú´ëÇÐ)
±³À°½Ã°£ 10¿ù 29ÀÏ ¿Â¶óÀÎ 17:30~18:00 Surgical Treatment for Pediatric Thyroid Cancer Ken Kazahaya(Children¡¯s Hospital of Philadelphia)
±³À°½Ã°£ 10¿ù 29ÀÏ ¿Â¶óÀÎ 16:30~17:00 Diabetes & Metabolism Journal (DMJ) Á¤Àΰæ(°æÈñÀÇ´ë °µ¿°æÈñ´ëº´¿ø)
±³À°½Ã°£ 10¿ù 29ÀÏ ¿Â¶óÀÎ 17:00~17:30 About development strategy of JCEM Paul Stewart(University of Leeds)
±³À°½Ã°£ 10¿ù 29ÀÏ ¿Â¶óÀÎ 17:30~18:00 Recent Progress of EnM and Future Strategy ÀÌ¿ø¿µ(°ºÏ»ï¼ºº´¿ø)
±³À°½Ã°£ 10¿ù 29ÀÏ ¿Â¶óÀÎ 16:30~16:50 Optimal Treatment in Patients with DM During COVID-19 Pandemic ¹®Áؼº(¿µ³²ÀÇ´ë)
±³À°½Ã°£ 10¿ù 29ÀÏ ¿Â¶óÀÎ 16:50~17:10 Management of Adrenal Insufficiency Under SARS-CoV-2 Infection Irina Bancos(Mayo Clinic)
±³À°½Ã°£ 10¿ù 29ÀÏ ¿Â¶óÀÎ 17:10~17:30 How to Manage Thromboembolic Risk Under SARS-CoV-2 Infection Beverley J Hunt(Thrombosis & Haemophilia Centre)
±³À°½Ã°£ 10¿ù 29ÀÏ ¿Â¶óÀÎ 17:30~17:50 Role of Vitamin D Supplement During COVID-19 ¹èÀçÇö(°í·Á´ëÇб³¾È¾Ïº´¿ø)
±âŸ 10¿ù 29ÀÏ ¿Â¶óÀÎ 17:50~18:00 Q&A ()